Capex of ₹3,000 crore over next two years
Increased from earlier ₹1,000 crore annually; 90% towards mid/large-scale manufacturing.
LAURUSLABS / guidance tracker
Keep management guidance in view.
Laurus Labs · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
capex
CDMO to reach 50% of total sales by 2030
Management reiterated target; ARV sales to remain constant in absolute terms.
EBITDA margin to sustain or improve in FY27
Confident in maintaining stable margins despite solvent price pressures.
Unit 7 first production block ready by March 2027
Greenfield project; additional blocks in FY28 with combined 2,000 m³ reactor volume.